Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | HTR2B | P41595 | 1/20 | 0.55 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | CTSC | P53634 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | FABP7 | O15540 | 1/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL630517 | 1.00 | TSHR (0.63) | TSHRHTR2CHTR2BBACE1CTSC | |
| SCHEMBL4069956 | 1.00 | TSHR (0.63) | TSHRHTR2CHTR2BBACE1CTSC | |
| Hydrochloric Acid SCHEMBL1000787 | 0.98 | TSHR (0.65) | TSHRHTR2CHTR2BBACE1CTSC | |
| Hydrochloric Acid SCHEMBL630516 | 0.98 | TSHR (0.65) | TSHRHTR2CHTR2BBACE1CTSC | |
| Hydrochloric Acid SCHEMBL693350 | 0.98 | TSHR (0.65) | TSHRHTR2CHTR2BBACE1CTSC | |
| SCHEMBL6727374 | 0.95 | TSHR (0.61) | TSHRHTR2CHTR2BBACE1GLA | |
| SCHEMBL630942 | 0.95 | TSHR (0.61) | TSHRHTR2CHTR2BBACE1GLA | |
| SCHEMBL28676037 | 0.94 | TSHR (0.60) | TSHRHTR2CHTR2BBACE1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL630943 | 0.94 | TSHR (0.64) | TSHRHTR2CHTR2BBACE1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL630941 | 0.94 | TSHR (0.64) | TSHRHTR2CHTR2BBACE1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106749438-A | A kind of Amadori compound synthesis method | 华宝香精股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| US-20130225819-A1 | USE OF AZIDES IN SYNTHESIS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-08-29 | — | — | US | claimed |
| US-5602161-A | ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-02-11 | — | — | US | claimed |
| EP-0676396-A1 | Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1995-10-11 | — | — | EP | claimed |
| JP-8253497-A | — | — | None | — | — | JP | disclosed |
| JP-56097266-A | — | — | None | — | — | JP | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-118556062-A | Compounds, pharmaceutical compositions and methods for treating, preventing or managing hyperproliferative disorders | 文赛克斯制药有限责任公司 | 2024-08-27 | — | — | CN | disclosed |
| EP-4269119-A1 | COLOR DEVELOPER, HEAT-SENSITIVE RECORDING MATERIAL, AND COATING MATERIAL FOR HEAT-SENSITIVE RECORDING LAYERS | Sanko Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-3922634-B1 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023178299-A1 | PRODRUGS OF GANAXOLONE | MARINUS PHARMACEUTICALS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| CN-116437913-A | Pharmaceutical compounds for treating complement-mediated disorders | 艾其林医药公司 | 2023-07-14 | — | — | CN | disclosed |
| US-4472380-A | CARBOXYALKYL DIPEPTIDE DERIVATIVES | MERCK & CO., INC. (US) | 1984-09-18 | — | — | US | disclosed |
| WO-1984003507-A1 | ENZYME INHIBITION | FERRING AB (SE) | 1984-09-13 | — | — | WO | disclosed |
| EP-0118280-A1 | Enzyme inhibition | Aktiebolaget Hässle (SE) | 1984-09-12 | — | — | EP | disclosed |
| EP-0086660-A2 | Renally active tetrapeptides | SMITHKLINE BECKMAN CORPORATION (US) | 1983-08-24 | — | — | EP | disclosed |
| US-4386075-A | IMPROVING KIDNEY FUNCTION | SMITHKLINE BECKMAN CORPORATION (US) | 1983-05-31 | — | — | US | disclosed |
| US-4374829-A | Aminoacid derivatives as antihypertensives | MERCK & CO., INC. (US) | 1983-02-22 | — | — | US | disclosed |
| JP-S5697266-A | PROLINE DERIVATIVE AND ITS PREPARATION | TANABE SEIYAKU CO LTD | 1981-08-05 | — | — | JP | disclosed |
| EP-0012401-A1 | Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1980-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225819-A1 | USE OF AZIDES IN SYNTHESIS | ABL1, ABL2, TST | TSHR 2217/4885HTR2C 1330/4885HTR2B 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.